SCHEMBL23601063

SCHEMBL23601063

CCN(c1cccc(/C(C)=C/C2(C)CC2)c1)c1nc2nncn2c2ccc(F)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601890 0.79 TP53 (0.39)
SCHEMBL23601889 0.79 SMN1; SMN2 (0.32)
SCHEMBL23576642 0.78 SMN1; SMN2 (0.31)
SCHEMBL29909520 0.78 SMN1; SMN2 (0.31)
SCHEMBL23601245 0.77
SCHEMBL24721230 0.74 PER2 (0.31)
SCHEMBL23601061 0.72 SMN1; SMN2 (0.35)
SCHEMBL23601988 0.72
SCHEMBL23578049 0.69 ABCG2 (0.42)
SCHEMBL29909895 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed